Sign Up Today and Learn More About AusperBio Stock
Invest in or calculate the value of your shares in AusperBio or other pre-IPO companies through EquityZen, part of Morgan Stanley.
AusperBio Stock (AUSB)
AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other major infectious diseases.
About AusperBio Stock
Founded
2019
Industries
Design, Software, Artificial Intelligence
AusperBio Press Mentions
Stay in the know about the latest news on AusperBio
Y Combinator Still Busiest Startup Investor In August As Nvidia Ramps Up Its Dealmaking Pace
news • Sep 14, 2026
Editor’s Picks: The Week That Was - Aug 31 - Sept 5
dealstreetasia • Sep 06, 2026
AusperBio Inks $120 Million Series C Financing
vcnewsdaily • Sep 03, 2026
Financings: Ausperbio’s $120M series C; Moderna’s $2.6B private placement
bioworld • Sep 02, 2026
Biopharma firm AusperBio secures $120m Series C to advance chronic hepatitis B therapies
dealstreetasia • Aug 31, 2026
Join now and verify your accreditation status to gain access to:
- AusperBio Current Valuation
- AusperBio Stock Price
- AusperBio Management
- Available deals in AusperBio and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- AusperBio Cap Table and Funding History by Share Class and Liquidity Preferences
- AusperBio Revenue and Financials
- AusperBio Highlights
- AusperBio Business Model
- AusperBio Risk Factors
- AusperBio Research Report from SACRA Research
Trading AusperBio Stock
How to invest in AusperBio stock?
Accredited investors can buy pre-IPO stock in companies like AusperBio through EquityZen funds. These investments are made available by existing AusperBio shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell AusperBio stock?
Shareholders can sell their AusperBio stock through EquityZen's private company marketplace. EquityZen's network includes over 480K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 56K private placements completed across 500+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
